In MPNs, it was demonstrated that JAK2 V617F allele burden identified patients with different clinical course: in PV and in ET, variant allele frequency of JAK2 V617F, was associated with a higher ratio of fibrotic transformation. This evidence concerns the gene JAK2 and essential thrombocythemia.